Omics Phenotyping of Endocrine Disease in the General Population
Metabolomics is a relatively new technology that provides information about levels of human metabolites, the low molecule products at the end (downstream) of the metabolic pathways of human physiology. In theory, metabolite profil...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MeMoSA
Metabolomics-driven Molecular Source Analysis for personaliz...
2M€
Cerrado
Recon4IMD
Reconstruction and Computational Modelling for Inherited Met...
8M€
Cerrado
T2DSystems
Development of a systems biomedicine approach for risk ident...
6M€
Cerrado
METAFLUX
Metabolic Flux Analysis and Cancer
4M€
Cerrado
CTQ2011-26603
UTILIZACION COMBINADA DE TECNICAS ANALITICAS Y QUIMIOMETRICA...
92K€
Cerrado
Duración del proyecto: 28 meses
Fecha Inicio: 2015-03-23
Fecha Fin: 2017-07-31
Líder del proyecto
REGION HOVEDSTADEN
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
200K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Metabolomics is a relatively new technology that provides information about levels of human metabolites, the low molecule products at the end (downstream) of the metabolic pathways of human physiology. In theory, metabolite profiles may more closely reflect the clinical phenotype and thus potentially improve risk prediction. Another advantage is that that they can be performed on non-invasive biofluids like urine. Several metabolomics studies have suggested that the metabolite profile of an individual can be used as a predictor of type 2 diabetes. However, evidence from large-scale population-based studies with comprehensive phenotypes of diabetes and thyroid disease is limited. The aim of the project is to identify urine metabolite profiles associated with risk of diabetes and thyroid disease and to investigate pathogenetic pathways by identifying genetic determinants of these metabolites. The project takes advantage of the long tradition of population-based and registry-based epidemiological research in Denmark. The experienced researcher will complete a training program supervised by two recognised Danish research institutions with complementary expertise in the fields of epidemiology and genetics, respectively. Hereby the experienced researcher will achieve competences in the field of statistical modelling of epidemiological data with repeated measures and use of the unique Danish registries for research. Furthermore, during the secondment at the partner institution the experienced researcher will receive training in genetic epidemiology. In return, knowledge of metabolomics will be translated to the beneficiary and partner organizations. It is expected that the results will provide novel insights into the pathophysiology of diabetes and thyroid disease and identify novel biomarkers to improve risk prediction in individuals.